Related Experiment Videos
Inflammatory arthropathies in children with chromosomal abnormalities
D H Ihnat1, G McIlvain-Simpson, K Conard
1Department of Pediatrics, Alfred I. duPont Institute, Wilmington, DE 19899.
The Journal of Rheumatology
|April 1, 1993
Summary
This study details a 14-year-old boy with trisomy 5q and 2p deletion experiencing inflammatory synovitis resembling juvenile rheumatoid arthritis. Aggressive medical intervention was necessary to manage his complex genetic disorder and associated joint disease.
Area of Science:
- Genetics
- Rheumatology
- Pediatrics
Background:
- Limited data exists on inflammatory synovitis linked to specific chromosomal abnormalities in pediatric and adult populations.
- Genetic disorders and rheumatic diseases often present complex challenges in diagnosis and management.
Observation:
- A 14-year-old male with trisomy 5q, terminal 2p deletion, and developmental delay presented with a 5-year history of polyarticular, symmetrical arthropathy.
- The patient's condition mimicked juvenile rheumatoid arthritis, necessitating treatment with NSAIDs, gold, and methotrexate.
- Complications included iridocyclitis, joint space narrowing with erosions, and flexion contractures.
Findings:
- Disease progression was noted despite initial treatments, with chlorambucil showing a slowing effect.
- The interplay between genetic abnormalities and inflammatory arthropathies remains poorly understood.
- Children with multiple disabilities require intensive medical care to foster independence.
Implications:
- This case highlights the potential for significant rheumatic manifestations in individuals with specific chromosomal aberrations.
- Further research is needed to elucidate the mechanisms connecting genetic disorders and inflammatory arthritis.
- Aggressive, multidisciplinary medical management is crucial for improving outcomes in children with complex genetic conditions and associated rheumatic diseases.